Recruiting Clinical Trials

Displaying 1 - 10 of 242 result(s)
Study Title Condition Phase Location
A Non-interventional Study Evaluating Injectable Treatments (Ofatumumab, Glatiramer Acetate and Interferon β1) in Patients With Relapsing Multiple Sclerosis [AIOLOS] Relapsing Multiple Sclerosis Not Given
  • Country: 
    Germany
Tracking the Immune Response to SARS-CoV-2 modRNA Vaccines in an Open-label Multicenter Study in Participants With Relapsing Multiple Sclerosis Treated With Ofatumumab s.c. (KYRIOS) Multiple Sclerosis Phase 4
  • Country: 
    Germany
A Phase I/Ib Study of Subcutaneous Recombinant Human NIZ985 ((hetIL-15) (IL-15/sIL-15Rα)) in Combination With Spartalizumab in Patients With Check Point Inhibitor (CPI) Relapsed Advanced Solid Tumors and Lymphoma In Escalation: All Patients With Solid Tumors and Lymphoma, In Expansion: Melanoma, Non-small Cell Lung Cancer Phase 1
  • Country: 
    United States
  • Country: 
    Belgium
  • Country: 
    Germany
  • Country: 
A 24-week, Multicenter, Randomized, Double-blind, Parallel-arm, Placebo-controlled Extension Study to Assess the Safety of CSJ117, When Added to Existing Standard of Care Asthma Therapy in Patients ≥18 Years of Age Asthma Phase 2
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Belgium
  • Country: 
A 12-week, Multicenter, Randomized, Double-blind, Parallel-arm, Placebo-controlled Study to Assess the Efficacy and Safety of CSJ117, When Added to Existing Asthma Therapy in Patients ≥ 18 Years of Age With Severe Uncontrolled Asthma. Asthma Phase 2
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Belgium
  • Country: 
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program Not Applicable
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies Allergic Rhinitis Not Given
  • Country: 
    Japan
International, Non-interventional, Post-Authorization Long-Term Safety Study of Lutathera, in Patients With Unresectable or Metastatic, Well-Differentiated, Somatostatin Receptor Positive, Gastroenteropancreatic Neuroendocrine Tumours Neuroendocrine Tumors Not Given
  • Country: 
    United States
  • Country: 
    France
  • Country: 
    Portugal
  • Country: 
A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive ... Sickle Cell Disease (SCD) Phase 2
  • Country: 
    United States
  • Country: 
    Belgium
  • Country: 
    Brazil
  • Country: 
A Multi-center, Open-label Study to Determine the Dose and Safety of Oral Asciminib in Pediatric Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP), Previously Treated With One or More Tyrosine Kinas ... Myeloid Leukemia, Philadelphia Positive Phase 1, Phase 2
  • Country: 
    United States
  • Country: 
    France
  • Country: 
    Germany
  • Country: